Midtrimester amniotic fluid leptin and insulin levels and subsequent gestational diabetes

Gynecol Obstet Invest. 2007;64(2):65-8. doi: 10.1159/000099149. Epub 2007 Jan 30.

Abstract

Aims: To evaluate midtrimester amniotic fluid leptin levels in pregnancies subsequently complicated by gestational diabetes.

Methods: We studied 32 pregnant women with gestational diabetes and a control group of 43 normal pregnancies with an adequate gestational age fetus. All underwent a midtrimester amniocentesis: leptin and insulin were measured in the amniotic fluid. Data were compared with the Mann-Whitney U-test.

Results: Median leptin concentrations in the amniotic fluid of the gestational diabetes mellitus patients were significantly higher than in the control group (15.1 vs. 7.9 ng/ml) (p = 0.001); amniotic insulin concentrations were also higher in the gestational diabetes mellitus than in the control group (0.67 vs. 0.38 microU/ml) (p = 0.02). Furthermore, amniotic fluid leptin levels were directly correlated with amniotic insulin concentrations; instead, there was no correlation with maternal BMI and birth weight.

Conclusion: Our data suggest that in pregnancies subsequently complicated by gestational diabetes, amniotic fluid leptin and insulin levels are higher in the early fetal period.

MeSH terms

  • Adult
  • Amniocentesis
  • Amniotic Fluid / metabolism*
  • Biomarkers / analysis
  • Birth Weight
  • Body Mass Index
  • Case-Control Studies
  • Diabetes, Gestational / epidemiology*
  • Female
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Insulin / analysis*
  • Leptin / analysis*
  • Male
  • Predictive Value of Tests
  • Pregnancy
  • Pregnancy Trimester, Second
  • Risk Assessment

Substances

  • Biomarkers
  • Insulin
  • Leptin